In an earlier study of inpatients with patients with type 1 diabetes receiving insulin detemir or insulin glargine, we reported that fasting glucose levels that are lower than 135 mg/dL or an acute increase in post-breakfast glucose levels are predictive of nocturnal asymptomatic hypoglycemia in patients with type 1 diabetes [24]. The gene discussed is INS; the disease is Hypoglycemia.